Forbes Medi-Tech seeks approval for cholesterol drug study
5th Sep 2005, 13:33 GMT
Forbes Medi-Tech has submitted an investigational new drug application with the FDA to initiate a US phase II clinical trial for its cholesterol-lowering drug, FM-VP4.
Latest news from Pharmaceutical Business Review Online:
- Celesio revenues, profits up
- Amgen arthritis drug shows sustained safety and efficacy
- Study supports cardiovascular safety of naproxen
- Cangene chickenpox drug granted orphan status
- Reata brain cancer therapy shows strong activity
- Novartis diabetes drug faces three month delay
- Favrille drug fails secondary goal
- Neurogen commences human testing of obesity drug
- Aeterna prostate cancer drug shows promise
- Isis says new drug effective against cholesterol